The 3rd Annual Biocompatibility Testing in Medical Devices Conference is taking place
on March 5-6, 2026, in Rome, Italy.
The conference is designed to address the latest advancements, regulatory changes, and challenges in ensuring the safety of medical devices. As regulatory frameworks such as ISO 10993, EU MDR, and FDA guidelines continue to evolve, manufacturers, toxicologists, notified bodies, and regulatory professionals must adapt to meet compliance requirements and ensure product safety.
on March 5-6, 2026, in Rome, Italy.
The conference is designed to address the latest advancements, regulatory changes, and challenges in ensuring the safety of medical devices. As regulatory frameworks such as ISO 10993, EU MDR, and FDA guidelines continue to evolve, manufacturers, toxicologists, notified bodies, and regulatory professionals must adapt to meet compliance requirements and ensure product safety.
This year’s event will focus on:
- The latest regulatory requirements for biocompatibility testing and toxicological risk assessment
- Innovative testing methodologies, including in vitro models, organ-on-a-chip, and AI-driven approaches
- Best practices for extractables & leachables (E&L) analysis and chemical characterization
- Material selection and safety considerations for novel medical device technologies
- Risk-based approaches to cytotoxicity, sensitization, and genotoxicity assessment
Through interactive panel discussions, case study presentations, and hands-on workshops, attendees will gain practical insights into effective strategies for biocompatibility assessment and ensuring compliance with global regulations.
As the medical device industry continues to evolve, biocompatibility testing remains a critical component in ensuring patient safety and regulatory compliance. With the continuous updates in ISO 10993 standards, the increasing complexity of chemical characterization, and the push towards alternative in vitro methods, it is essential for professionals in the field to stay ahead of the latest developments.
This conference will bring together leading experts, regulatory representatives, and industry pioneers to discuss the latest regulatory updates, advanced testing methodologies, and best practices for ensuring the safety of medical devices. You will have the opportunity to engage in thought-provoking discussions, explore cutting-edge technologies, and network with professionals at the forefront of biocompatibility testing.
Whether you are a returning participant or planning to join us for the first time, we are thrilled to welcome you to this leading platform for knowledge exchange and networking in the biocompatibility space.









